Growth disorders—encompassing short stature, delayed or precocious puberty, and disproportionate growth—require a structured evaluation of the GH–IGF axis, pituitary function, and contributory endocrine/metabolic factors. At Southern Medical Supplies Limited (SMSL), we provide a comprehensive menu for pediatric and adult assessment, including growth hormone (GH) baseline and dynamic testing support, IGF-1 and IGFBP-3, thyroid panels (TSH, free T4/T3), adrenal markers (cortisol, ACTH, 17-OHP), gonadotropins/sex steroids (LH, FSH, estradiol, testosterone), and adjunctive metabolic/nutritional biomarkers (e.g., vitamin D, ferritin) with optional targeted molecular assays for genetic etiologies of short stature/overgrowth. Our portfolio spans ELISA, chemiluminescent immunoassay, molecular, and clinical chemistry formats sourced from a broad network of trusted partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the sensitivity, specificity, and reproducibility clinicians need to diagnose causes, guide therapy (including GH treatment decisions), and monitor outcomes with confidence.